Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001998663-26-000002

Chief Operating Officer acquired 4,386 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Prince Joshua S. Chief Operating Officer 2025-12-31 Grant or award +4,386 $0.56 $2,468 15,249 D
Loading xslF345X05/edgardoc.xml…